Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Alejandro Martínez‐Bueno"'
Autor:
Jordi Bertran-Alamillo, Ana Giménez-Capitán, Ruth Román, Sara Talbot, Rebecca Whiteley, Nicolas Floc’h, Elizabeth Martínez-Pérez, Matthew J. Martin, Paul D. Smith, Ivana Sullivan, Mikkel G. Terp, Jamal Saeh, Cristina Marino-Buslje, Giulia Fabbri, Grace Guo, Man Xu, Cristian Tornador, Andrés Aguilar-Hernández, Noemí Reguart, Henrik J. Ditzel, Alejandro Martínez-Bueno, Núria Nabau-Moretó, Amaya Gascó, Rafael Rosell, J. Elizabeth Pease, Urszula M. Polanska, Jon Travers, Jelena Urosevic, Miguel A. Molina-Vila
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-24 (2023)
Abstract Background Drugs targeting the spindle assembly checkpoint (SAC), such as inhibitors of Aurora kinase B (AURKB) and dual specific protein kinase TTK, are in different stages of clinical development. However, cell response to SAC abrogation i
Externí odkaz:
https://doaj.org/article/0503e7da1cca40afa0953e96d2560af7
Publikováno v:
Molecules, Vol 28, Iss 7, p 2887 (2023)
The synthesis, characterization and liquid crystalline and electrochemical properties of novel triarylamines, in which the triphenylamine platform is non-symmetrically modified with a 4-(6-oxyhexyloxy)benzoic acid group, are reported. Compounds show
Externí odkaz:
https://doaj.org/article/bb8d5cf518c74e2f875bf8c28539f3a7
Autor:
Cristina Aguado, Cristina Teixido, Ruth Román, Roxana Reyes, Ana Giménez‐Capitán, Elba Marin, Carlos Cabrera, Nuria Viñolas, Sergi Castillo, Silvia Muñoz, Ainara Arcocha, Laura López‐Vilaró, Ivana Sullivan, Erika Aldeguer, Sonia Rodríguez, Irene Moya, Santiago Viteri, Andrés Felipe Cardona, Ramon Palmero, Cristina Sainz, Miguel Mesa‐Guzmán, Maria D. Lozano, Andrés Aguilar‐Hernández, Alejandro Martínez‐Bueno, María González‐Cao, Elena Gonzalvo, William P. J. Leenders, Rafael Rosell, Luis M. Montuenga, Aleix Prat, Miguel A. Molina‐Vila, Noemi Reguart
Publikováno v:
Molecular Oncology, Vol 15, Iss 2, Pp 350-363 (2021)
MET inhibitors have shown activity in non‐small‐cell lung cancer patients (NSCLC) with MET amplification and exon 14 skipping (METΔex14). However, patient stratification is imperfect, and thus, response rates have varied widely. Here, we studied
Externí odkaz:
https://doaj.org/article/5db041644f0248ee90bd178c373b1867
Autor:
Sergio Villatoro, Clara Mayo‐de‐las‐Casas, Núria Jordana‐Ariza, Santiago Viteri‐Ramírez, Mónica Garzón‐Ibañez, Irene Moya‐Horno, Beatriz García‐Peláez, María González‐Cao, Umberto Malapelle, Ariadna Balada‐Bel, Alejandro Martínez‐Bueno, Raquel Campos, Noemí Reguart, Margarita Majem, Remei Blanco, Ana Blasco, María J. Catalán, Xavier González, Giancarlo Troncone, Niki Karachaliou, Rafael Rosell, Miguel A. Molina‐Vila
Publikováno v:
Molecular Oncology, Vol 13, Iss 12, Pp 2633-2645 (2019)
Many advanced cases of cancer show central nervous system, pleural, or peritoneal involvement. In this study, we prospectively analyzed if cerebrospinal fluid (CSF), pleural effusion (PE), and/or ascites (ASC) can be used to detect driver mutations a
Externí odkaz:
https://doaj.org/article/768780ab545245d49c5080fab9f9fe1b
Autor:
Miriam Abad, Alejandro Martínez-Bueno, Gracia Mendoza, Manuel Arruebo, Luis Oriol, Víctor Sebastián, Milagros Piñol
Publikováno v:
Polymers, Vol 13, Iss 5, p 684 (2021)
Hybrid linear–dendritic block copolymers (LDBCs) having dendrons with a precise number of peripheral groups that are able to supramolecular bind functional moieties are challenging materials as versatile polymeric platforms for the preparation of f
Externí odkaz:
https://doaj.org/article/243519de73e24f3bb579114c80d8a066
Publikováno v:
Supramolecular Nanotechnology. :425-446
Autor:
Juan F. Cueva, Isabel Palacio, Cristina Churruca, Ana Herrero, Beatriz Pardo, Manuel Constenla, Ana Santaballa, Luis Manso, Purificación Estévez, Constanza Maximiano, Marta Legerén, Gloria Marquina, Ana de Juan, María Quindós, Luisa Sánchez, Arantzazu Barquin, Isaura Fernández, Cristina Martín, Asunción Juárez, Teresa Martín, Yolanda García, Alfonso Yubero, Alejandro Gallego, Alejandro Martínez Bueno, Eva Guerra, Antonio González-Martín
Publikováno v:
European Journal of Cancer. 182:3-14
Autor:
José Manuel Pérez-García, Marta Vaz Batista, Patricia Cortez-Castedo, Manuel Ruiz Borrego, Juan Miguel Cejalvo, Juan de la Haba-Rodríguez, Laia Garrigós, Fabriccio Racca, Sonia Servitja, Salvador Blanch, Maria Gión, Mónica Nave, Adela Fernández, Alejandro Martínez-Bueno, Antonio Llombart-Cussac, Miguel Sampayo-Cordero, Andrea Malfettone, Javier Cortés, Sofía Braga
Publikováno v:
Cancer Research. 83:PD7-02
Background: The antibody-drug conjugate trastuzumab deruxtecan (T-DXd) significantly improved survival outcomes of HER2-low advanced breast cancer (ABC) patients (pts) compared to standard chemotherapy in the DESTINY-Breast04 trial. DEBBRAH is assess
Autor:
Jordi Bertrán-Alamillo, John Travers, Sara Talbot, Rebecca Whiteley, Ana Giménez-Capitán, Ruth Román, Sonia Rodríguez, Erika Aldeguer, Josep Castellví, Alejandro Martínez-Bueno, Andrea Martella, Jamal Saeh, Giulia Fabbri, Rafael Rosell, Urszula Polanska, Jelena Urosevic, Miguel A. Molina-Vila
Publikováno v:
Cancer Research. 82:2642-2642
Background: Aurora kinase B (AURKB) plays a key role in the regulation of mitosis, and AURKB inhibitors are in Phase II-III clinical trials. We reported previously that Chr22q11 amplification, leading to BID overexpression, was associated with apopto
Autor:
Cristina A. Aguado, Beatriz Garcia, Andrés Aguilar-Hernández, Alejandro Martínez-Bueno, Marta Vives-Usano, Florencia Garcia-Casabal, Ruth Román, Ekaterina Meshoulam, Erika Aldeguer, Nuria Jordana-Ariza, Juan José García-Mosquera, Carlos Cabrera, Santiago Viteri, Sonia Rodríguez, Laura Berrocal-Gómez, Pablo Rubinstein, Clara Mayo-de-las-Casas, Rafael Rosell, Miguel Ángel Molina-Vila
Publikováno v:
Cancer Research. 82:1610-1610
Background: A significant percentage of patients (p.) with solid tumors present with pleural effusion or ascitic fluid during disease history. Although isolation of viable malignant cells from these fluids for drug screening and other experimental pu